Delivery Order SPE2DR25D1202-SPE2DR26F71YM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count unit) with a ceiling value of $1,487.88. This non-set-aside, firm fixed-price delivery order is scheduled for completion by October 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,431.02 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 40 mg capsules (30-count) with an ultimate completion date of September 11, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Duloxetine HCL DR 30 mg capsules (1,000 units) with a ceiling value of $1,129.80. This firm fixed-price delivery order, with an ultimate completion date of November 5, 2025, represents a non-competitive set-aside award to support federal pharmaceutical procurement needs. The product will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $3,470.07 to AmerisourceBergen Drug Corp for the supply of 1,000 units of Duloxetine HCl DR 20 mg capsules. This order, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units) valued at $1,979.60. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction. The order is scheduled for ultimate completion by September 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,133.54 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 20 mg capsules (1,000 count). This non-compete, firm fixed-price delivery order is set to be completed by October 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger indefinite delivery contract (IDC) vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (90-count units) valued at $3,416.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 24, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the open competition procurement process....
- The Defense Logistics Agency awarded a $1,919.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 1,000 capsules of Duloxetine HCL DR 20 mg. This non-set-aside contract, which is due for completion by August 13, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Duloxetine HCL DR 20 mg capsules (60-count units) valued at $1,688.88. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Duloxetine HCl DR 40 mg capsules (30-count) with a ceiling value of $1,110.54. The award was made on July 22, 2025, under a firm fixed-price delivery order contract with an ultimate completion date of July 23, 2025. This non-set-aside award represents a competitive procurement and will be performed at the vendor's Conshohocken...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71YMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Duloxetine HCL DR 30 mg capsules (1,000 units) with a contract ceiling value of $2,905.39. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded to the vendor. Performance will take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare programs. The company maintains an extensive portfolio of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Duloxetine, a commonly prescribed antidepressant and anxiety medication, exemplifies the routine pharmaceutical supply chain support the company provides to federal customers through its established DLA prime vendor relationship, enabling efficient fulfillment of medical commodity needs for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/4/25 |